From research grant award dinners to new revelations in the field of myeloma to heartfelt patient experiences blogged live from the event, the IMF’s presence at the 59th annual meeting of the American Society of Hematology this December 8, 2017 to December 12, 2017, was tremendous. We invite you to take part in all of last weekend’s events.

Generous Donations Help Fund 2018 Brian D. Novis Research Grants

The IMF awarded its 2018 Brian D. Novis Research Grants in a ceremony on Saturday, December 9, 2017, at ASH in Atlanta. For 20 years, the IMF has funded promising clinical investigators in the field of multiple myeloma. These grants are made possible through the generous donations of private individuals and IMF Member Fundraisers held across the country.

(The IMF brings myeloma support group leaders, patients, and caregivers to Atlanta for the #ASH17 meeting.
Left to Right: Nancy Bruno, Cindy Chmielewski, Linda Huguelet, Teresa Miceli, Jack Aiello, Robin Tuohy, Michael Tuohy, Tiffany Williams, John DeFlice, Laura Mooney, and Yelak Biru.)

The True Warriors on the Frontlines of #ASH17

Myeloma patients, caregivers, and Support Group Leaders joined forces at this site to blog live all weekend long. Linda Huguelet compared her myeloma journey to an Ironman Competition and was “ever encouraged by the passion of the many researchers working to beat myeloma!” Twenty-three-year myeloma survivor Jack Aiello took a different approach and provided his summary of top myeloma abstracts. Read these and more blogs now.

Watch a Replay of the IMF Pre-ASH Satellite Symposium

Nearly 1,000 medical professionals attended the IMF’s Satellite Symposium on Friday, December 8. Catch a replay of this session, Getting Clear Answers to Complex Treatment Challenges in Multiple Myeloma: Case Discussions.

 

Catch a Replay of the IMWG Conference Series

Broadcast live from ASH on Monday evening, December 11, the International Myeloma Working Group (IMWG) Conference Series featured a lively debate amongst myeloma experts and colleagues Dr. Brian G.M. Durie (IMF Chairman of the Board), Dr. Joseph Mikhael (Mayo Clinic – Scottsdale, Arizona), and Dr. Paul G. Richardson (Dana-Farber Cancer Institute – Boston).

Myeloma Experts Share the Latest and Greatest News from #ASH17

The IMF was live capturing video interviews with top hematologists/oncologists who attended this year’s ASH. The following leading myeloma experts provided overviews of this year’s meeting: Rafat Abonour, MD (Indiana University Simon Cancer Center – Indianapolis) and Nizar J. Bahlis, MD (Southern Alberta Cancer Research Institute - Calgary, AB, Canada).

Also, we talked to Adam Cohen, MD (Abramson Cancer Center – University of Pennsylvania – Philadelphia) on Safety and Efficacy of CART-BCMA with Cyclophosphamide Conditioning for Refractory Multiple Myeloma.

 

Patients and Support Group Leaders Provide Their Perspectives on #ASH17

Watch a series of videos of patients and myeloma Support Group Leaders who attended this year’s ASH annual meeting. Myeloma patient and Support Group Leader John Deflice attended ASH to gather as much information possible about the latest myeloma research to share with his home support group when he returns to Sante Fe, New Mexico.

Nancy Bruno, the IMF’s Director of Southeast Regional Support Groups, shares how important it is for patients to become educated about the latest treatments available for myeloma, so they can make informed decisions jointly with their healthcare team.

Finally, Teresa Miceli, BSN, OSN and myeloma Support Group Leader, talks about the excitement surrounding adoptive cellular therapy, or CAR T-cell therapy, which she thinks will be revolutionary in hematology - and especially in the world of multiple myeloma in the future.

Don’t Miss Next Year’s Best of ASH 2017 Webinar

Dr. Brian G.M. Durie discusses key takeaways from the annual conference and explains how this new and important information relates to myeloma patients, caregivers, and other members of the myeloma community. Don't miss this free IMF webinar presentation with a Q&A session on Thursday, January 11, 2018, at 4 p.m. PT / 7 p.m. ET

 

 

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.